Ampelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway
Crossref DOI link: https://doi.org/10.1371/journal.pone.0159191
Published Online: 2016-07-08
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Zhou, Yong
Wu, Ying
Qin, Yu
Liu, Lei
Wan, Jing
Zou, Lingyun
Zhang, Qianyong
Zhu, Jundong
Mi, Mantian
Funding for this research was provided by:
the “12the Five year plan”for National Key Technology Research and Development Program (2012BAI35B02)
Version of Record valid from 2016-07-08
